Studying Polycystic Ovary Syndrome Using Patient Data and Blood Samples
Observes women with polycystic ovary syndrome, collecting their health data and blood samples.
Plain-language title generated from the registry record
Registry title: Multidisciplinary Diagnosis and Treatment of Polycystic Ovary Syndrome
Key facts
- Where
- Shanghai, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 18 to 45 with polycystic ovary syndrome (PCOS). It collects clinical data and blood samples. There is no treatment given.
- Age
- 18 to 45 years
- Sex
- Women only
- Disease stage
- Polycystic ovary syndrome (PCOS); no stage is given.
- Earlier treatment
- Women who used certain blood sugar drugs in the last 3 months cannot join, such as thiazolidinediones, metformin, SGLT-2 drugs, acarbose or GLP-1RA. Women who used drugs for PCOS such as letrozole, clomiphene, birth control pills, glucocorticoids, gonadotropins, GnRH agonists or anti-androgens cannot join.
Main reasons for not taking part
- Other causes of missed ovulation or too many male hormones, such as premature ovarian failure, thyroid problems or adrenal tumors
- Abnormal liver or kidney function (3 times the upper limit of normal or more)
- Type 1 diabetes or other secondary diabetes
- History of cancer, severe infection or other serious long-term illness
- Mental illness or dementia
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
Source: NCT06047574, who can take part
Where in China
- Department of Endocrinology, Shanghai Tenth People's HospitalShanghai, ChinaContact: Manna Zhang, Ph.DTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Shanghai 10th People's Hospital
- Trial code
- NCT06047574
- Record updated
- 9 March 2026
- Original description
The investigators collected clinical data and serum samples of patients with polycystic ovary syndrome (PCOS) in this study, used statistical software such as SPSS for date analysis, and used experimental techniques such as ELISA and flow cytometry to detect serum samples, aiming to explore the relationship between the body anthropometry, skin conditions, psychosomatic status, diet, sleep, exercise, glucose and lipid metabolism, gonadal hormones, and body fat distribution in patients with polycystic ovary syndrome, and to discovery new biomarkers. Multidisciplinary exploration of the mechanisms of disease occurrence and development, the establishment of a PCOS multicenter, multidisciplinary and multidimensional clinical research database, combined with the established statistical analysis strategy for big data and analysis, to promote the realization of more accurate personalized medicine.Read full original descriptionShow less
Multidisciplinary Combined Precise Diagnosis and Treatment of Polycystic Ovary Syndrome
The investigators collected clinical data and serum samples of patients with polycystic ovary syndrome (PCOS) in this study, used statistical software such as SPSS for date analysis, and used experimental techniques such as ELISA and flow cytometry to detect serum samples, aiming to explore the relationship between the body anthropometry, skin conditions, psychosomatic status, diet, sleep, exercise, glucose and lipid metabolism, gonadal hormones, and body fat distribution in patients with polycystic ovary syndrome, and to discovery new biomarkers. Multidisciplinary exploration of the mechanisms of disease occurrence and development, the establishment of a PCOS multicenter, multidisciplinary and multidimensional clinical research database, combined with the established statistical analysis strategy for big data and analysis, to promote the realization of more accurate personalized medicine.
Inclusion: Female aged 18- 45.
Exclusion: Use hypoglycemic drugs that may affect insulin resistance and androgen levels in the last 3 months, including thiazolidinediones, metformin, SGLT-2, and acarbose and GLP-1RA and other drugs; Use letrozole, clomiphene, oral contraceptives, glucocorticoids, gonadotropins, gonadotropin-releasing hormone agonists, anti-androgens (spironolactone, Cyproterone acetate, flutamide, etc.) and other drugs for the treatment of PCOS; Ovulatory disorders caused by premature ovarian failure, pituitary amenorrhea, hypothalamic amenorrhea, and thyroid dysfunction; Congenital adrenal hyperplasia, reservoir Hin syndrome, hyperprolactinemia, adrenal tumors and other diseases that cause hyperandrogenism; Type 1 diabetes, single gene mutation diabetes, or pancreatic damage Diabetes or other secondary diabetes caused by diabetes; History of malignant tumors; Severe infection, severe anemia, neutropenia and other systemic chronic diseases; Mental illness, dementia or other cognitive behavioral problems; Female patients younger than 18 years old or older than 45 years old; Abnormal liver or renal function((≥ 3 times of the upper limit of normal range); Undergo total hysterectomy or ovarian adnexectomy.